B2DB — Who said what, where, and when

Caroline Haegeman

Co-Founder & COO, Athernal Bio

Athernal Bio is developing targeted immunotherapies to treat high-risk blood cancer precursor conditions — intercepting cancers like AML before they start.

Events Caroline Haegeman has spoken at